Fludrocortisone Acetate 0.1 mg Oral Tablet: Dosing, Monitoring, and Management
Standard Dosing
Most patients with primary adrenal insufficiency should take 50–200 µg (0.05–0.2 mg) fludrocortisone as a single daily dose taken upon awakening, with 100 µg (0.1 mg) daily being the most common starting dose. 1, 2
Dosing by Population:
- Adults with PAI: 50–200 µg daily, typically starting at 100 µg 1, 2
- Children and younger adults: Often require higher doses, up to 500 µg daily due to physiological differences 1, 3
- Pregnancy (third trimester): May require up to 500 µg daily due to progesterone's anti-mineralocorticoid effects 1
- Salt-losing congenital adrenal hyperplasia: 100–200 µg daily 2
Critical Administration Details:
- Take as a single morning dose upon awakening—never use alternate-day dosing 1, 3
- Tablets may be kept at room temperature despite package labeling requiring refrigeration (decay rate only 0.1% in 6 months at room temperature) 1
- Must be taken daily without interruption to prevent dangerous electrolyte fluctuations and adrenal crisis 3
Monitoring Parameters
Clinical Assessment (at every visit):
- Blood pressure in both supine AND standing positions: Orthostatic hypotension indicates under-replacement; hypertension indicates over-replacement 1, 4, 3
- Salt craving or lightheadedness: Suggests under-replacement 1, 4
- Peripheral edema: Suggests over-replacement 1, 4
- Weight monitoring: Assess for fluid retention 1
Laboratory Monitoring:
- Serum sodium and potassium: Low sodium or high potassium warrant dose increases by 0.05 mg increments 4, 2, 5
- Plasma renin activity (PRA): Target the upper half of normal range; low-normal PRA suggests over-replacement, elevated PRA suggests under-replacement 4, 5, 6
- Monitor at baseline, then at least annually 1, 4
Follow-up Schedule:
- Annual minimum review with assessment of health, well-being, weight, blood pressure, and serum electrolytes 1, 4
- Screen periodically for new autoimmune disorders (particularly hypothyroidism) 1
- Bone mineral density every 3–5 years to assess for glucocorticoid-related complications 1
Contraindications and Drug Interactions
Absolute Contraindications:
- Systemic fungal infections (general corticosteroid contraindication) 2
Medications to AVOID (interact dangerously with fludrocortisone):
- Diuretics (all types, including thiazides, loop diuretics) 1, 4, 3
- Acetazolamide 1, 4
- NSAIDs 1, 4, 3
- Carbenoxolone and licorice (potentiate mineralocorticoid effects, causing hypertension) 1, 4, 3
- Grapefruit juice (potentiates mineralocorticoid effects) 1, 4, 3
Medications Requiring Dose Adjustment:
- Drospirenone-containing contraceptives: May require increased fludrocortisone dose 1
- Digitalis glycosides: Enhanced risk of arrhythmias due to hypokalemia; monitor potassium closely 2
- Potassium-depleting diuretics and amphotericin B: Enhanced hypokalemia risk; check potassium frequently 2
- Oral anticoagulants: Decreased prothrombin time response 2
Use with Caution:
- Hypothyroidism or cirrhosis: Enhanced corticosteroid effects 2
- Ocular herpes simplex: Risk of corneal perforation 2
- Nonspecific ulcerative colitis, diverticulitis, peptic ulcer disease: Risk of perforation 2
- Renal insufficiency, hypertension, osteoporosis, myasthenia gravis: Requires careful monitoring 2
Adverse Effects and Management
Common Adverse Effects:
- Hypertension: Reduce dose by 0.05 mg but never discontinue completely (risk of adrenal crisis) 1, 4, 3
- Peripheral edema: Indicates over-replacement; reduce dose 1, 4
- Hypokalemia: Enhanced with concurrent potassium-depleting drugs; supplement potassium if needed 2
- Hypernatremia: Monitor electrolytes regularly 7
Serious Adverse Effects:
- Congestive heart failure: Especially with chronic use or over-replacement 7
- Hyperglycemia: Monitor in diabetic patients 7
- Arrhythmias: Particularly with concurrent digitalis use and hypokalemia 2
- Psychic derangements: Range from euphoria to severe depression or psychosis 2
Signs of Under-Replacement (Common Pitfall):
- Under-replacement is more common than over-replacement and predisposes to recurrent adrenal crises 1, 3
- Persistent salt craving, orthostatic hypotension, lightheadedness, elevated PRA, hyponatremia, hyperkalemia 1, 4, 5
- Do not compensate for mineralocorticoid under-replacement by increasing glucocorticoid doses 1
Special Situations and Dose Adjustments
Pregnancy:
- Small dose adjustments may be needed, particularly in the third trimester (up to 500 µg daily) due to progesterone's anti-mineralocorticoid activity 1
- Parenteral hydrocortisone required during delivery 1
Surgery and Invasive Procedures:
- Continue fludrocortisone at usual dose 1
- Increase glucocorticoid (hydrocortisone) coverage as needed 1
Hypertension Management:
- If essential hypertension develops, reduce fludrocortisone dose but never stop completely 1
- Add vasodilator therapy if needed rather than discontinuing mineralocorticoid 1
- Monitor for hyperkalemia with dose reduction 4
High Ambient Temperature:
- May require dose adjustments to avoid sodium depletion 6
Patient Education Essentials
Critical Safety Information:
- Wear medical alert identification jewelry and carry a steroid alert card at all times 1
- Carry emergency injectable hydrocortisone (100 mg IM) and know how to self-administer 1, 4
- Never skip doses or attempt alternate-day dosing (risk of adrenal crisis) 3
Dietary Recommendations:
- Consume salt and salty foods ad libitum (without restriction) 1, 3
- Avoid potassium-containing salt substitutes (often marketed as "healthy salts") 1, 3
- Avoid licorice and grapefruit juice completely 1, 4, 3
Stress Dose Protocols:
- Double or triple hydrocortisone dose during febrile illness, gastroenteritis, or significant physical stress 4
- Use emergency injectable hydrocortisone (100 mg IM) if unable to take oral medications or during severe illness 4
- Seek immediate medical attention for signs of adrenal crisis 1
Missed Dose Instructions:
Algorithm for Dose Titration
Starting dose: 100 µg (0.1 mg) daily upon awakening 2
If Under-Replacement Signs Present (salt craving, orthostatic hypotension, elevated PRA, hyponatremia, hyperkalemia):
- Increase by 50 µg (0.05 mg) increments 4, 2
- Reassess in 2–4 weeks with blood pressure (supine/standing), electrolytes, and PRA 4
- Continue titrating until symptoms resolve and PRA in upper normal range 4, 6
If Over-Replacement Signs Present (hypertension, edema, suppressed PRA):
- Decrease by 50 µg (0.05 mg) but never discontinue completely 1, 4, 2
- Monitor for rebound hyperkalemia 4
- Consider adding vasodilator if hypertension persists despite dose reduction 1